New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 28, 2013
16:26 EDTENDPEndo Health reaffirms FY13 adjusted EPS view $4.40-$4.70, consensus $4.55
Reaffirms FY13 revenue view $2.8B-$2.95B, consensus $2.92B. Sees FY13 CapEx $120M.
News For ENDP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 28, 2015
09:50 EDTENDPAllergan plans for generic version of Endo's Fortesta blocked, Bloomberg reports
A judge upheld Endo's (ENDP) patents on Fortesta expiring in 2018 and blocked Allergan's (AGN) bid to launch a generic version of the testosterone gel, according to Bloomberg.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use